Condition
Benign Prostate Enlargement
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Unknown2
Recruiting1
Enrolling By Invitation1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07638865Not ApplicableRecruitingPrimary
Oxiblume:CoQ10 (Ralivia) Therapy for Benign Prostatic Hyperplasia:
NCT07357168Not ApplicableEnrolling By InvitationPrimary
Electromagnetic Field Therapy Versus Aerobic Exercise on Prostatic Function in Elderly With Benign Prostatic Hyperplasia
NCT05765331Not ApplicableUnknownPrimary
The Impact of Chatbot-aid on Promoting Self-management of Men's Health in the Post COVID-19 Era
NCT03486639Unknown
Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity
Showing all 4 trials